GYRE Competitors & Alternatives
Compare Gyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
GYRE
Main Stock$7.68
Tradestie Score
52
Market Cap
$688.47M
P/E Ratio
367.5
Revenue Growth
0.3%
Analyst Upside
+143.1%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$14.41
|
$757.72M | - | 53 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$31.09
|
$748.90M | - | 62 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$16.74
|
$726.21M | 8.1 | 59 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$16.70
|
$718.62M | - | 64 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$34.75
|
$715.25M | - | 54 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$128.32
|
$699.30M | - | 60 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.93
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$9.90
|
$670.30M | - | 55 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.22
|
$665.30M | - | 50 | Compare |
More GYRE Analysis
Data updated: May 01, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry